Top Markets
Coin of the day
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rangering i aksjer #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Aksjekurs
$48.45
Markedsverdi
$1.39B
Endring (1 dag)
1.16%
Endring (1 år)
-
Land
US
Handel LB Pharmaceuticals Inc Common Stock (LBRX)

Kategori

Historikk for aksjesplitt for LB Pharmaceuticals Inc Common Stock (LBRX)
Aksjen LB Pharmaceuticals Inc Common Stock (symbol: LBRX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 28, 2026.
Én LBRX-aksje kjøpt før Aug 28, 2026 tilsvarer i dag 0 LBRX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH